Large Prostate Volume Does Not Negatively Impact Health-Related Quality of Life in Patients with Prostate Cancer Treated with Ultrahypofractionated Stereotactic Body Radiotherapy.
Piotr MileckiAnna AdamskaAnna RucinskaGrzegorz PałuckiAgnieszka SzumiłoAgnieszka SkrobałaAgata JoddaMichał MichalakPublished in: Journal of personalized medicine (2023)
) does not appear to negatively impact HRQOL outcomes at two years in patients with localized prostate cancer treated with ultrahypofractionated SBRT administered with the CyberKnife system.